- Home
- DRUG vs FFWM Comparison
DRUG vs FFWM Comparison
Compare DRUG & FFWM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRUG
- FFWM
- Stock Information
- Founded
- DRUG 2019
- FFWM 1990
- Country
- DRUG United States
- FFWM United States
- Employees
- DRUG N/A
- FFWM N/A
- Industry
- DRUG Pharmaceuticals and Biotechnology
- FFWM Major Banks
- Sector
- DRUG Health Care
- FFWM Finance
- Exchange
- DRUG Nasdaq
- FFWM Nasdaq
- Market Cap
- DRUG 345.6M
- FFWM 406.2M
- IPO Year
- DRUG N/A
- FFWM 2014
- Fundamental
- Price
- DRUG $59.91
- FFWM $5.54
- Analyst Decision
- DRUG Strong Buy
- FFWM Buy
- Analyst Count
- DRUG 9
- FFWM 2
- Target Price
- DRUG $81.67
- FFWM $6.25
- AVG Volume (30 Days)
- DRUG 106.1K
- FFWM 611.2K
- Earning Date
- DRUG 08-11-2025
- FFWM 10-28-2025
- Dividend Yield
- DRUG N/A
- FFWM N/A
- EPS Growth
- DRUG N/A
- FFWM N/A
- EPS
- DRUG N/A
- FFWM N/A
- Revenue
- DRUG N/A
- FFWM $104,325,000.00
- Revenue This Year
- DRUG N/A
- FFWM $164.53
- Revenue Next Year
- DRUG N/A
- FFWM $9.57
- P/E Ratio
- DRUG N/A
- FFWM N/A
- Revenue Growth
- DRUG N/A
- FFWM N/A
- 52 Week Low
- DRUG $0.94
- FFWM $4.42
- 52 Week High
- DRUG $79.02
- FFWM $8.52
- Technical
- Relative Strength Index (RSI)
- DRUG 73.27
- FFWM 41.12
- Support Level
- DRUG $48.90
- FFWM $5.67
- Resistance Level
- DRUG $54.63
- FFWM $5.90
- Average True Range (ATR)
- DRUG 3.94
- FFWM 0.17
- MACD
- DRUG 0.80
- FFWM -0.06
- Stochastic Oscillator
- DRUG 90.58
- FFWM 8.53
About DRUG Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
About FFWM First Foundation Inc.
First Foundation Inc is a financial services company. It is engaged in providing investment management and financial planning services for high-net-worth individuals, retirement plans, charitable institutions, and private foundations. The company focuses on segments namely Banking and Wealth Management. It also offers loans to individuals and entities that own and operate multifamily residential and commercial real estate properties as well as business banking products and services to small to moderate-sized businesses, professional firms, and consumer banking products and services to individuals.